apalutamide will decrease the level or outcome of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with drugs which have been CYP3A4 substrates may result in decreased publicity to these medicines.It’s not real that Wymzya Fe